Riskpilot← Back to searchSign inGet full accessUV Clinical A/S
A/SActiveCVR 38401572Strandvejen 100Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20174 employeeswww.uvclinical.com
Revenue 2024
DKK 392K
-82% vs 2023
EBITDA margin
-660.3%
-453% vs 2023
Equity ratio
87.1%
Financial strength
Net profit 2024
DKK -1,9M
-354% vs 2023
| Revenue | DKK 392K | -82% |
| EBITDA | DKK -2,6M | -453% |
| Net profit | DKK -1,9M | -354% |
| Total assets | DKK 23M | +105% |
| Equity | DKK 20,1M | +146% |
| Employees | 4 | — |
Legal name
UV Clinical A/S
CVR number
38401572
Legal form
Aktieselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
1. februar 2017
Share capital
DKK 858.606
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør sammen med formanden for bestyrelsen eller af den samlede
bestyrelse.
Company purpose
Virksomhedens formål er at udvikle, kommercialisere og sælge desinfektion af venekatetre og entracheale katetre ved hjælp af UVC LED lys.
Address
Strandvejen 100
Phone
+4520203005
Email
rsj@uvclinical.com
Website
www.uvclinical.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -411 | 33 | 151 | 2.235 | 392 |
| Staff expenses | -635 | -17 | -1.431 | -2.704 | -2.983 |
| EBITDA | -1.047 | 16 | -1.280 | -469 | -2.591 |
| Depreciation & amort. | -58 | -58 | -5 | -0 | -0 |
| EBIT | -1.105 | -42 | -1.285 | -469 | -2.591 |
| Net financials | -172 | 2.290 | -13 | 2 | 26 |
| Profit before tax | -1.277 | 2.248 | -1.298 | -467 | -2.565 |
| Tax | -128 | -0 | -1.029 | -50 | -670 |
| Net profit | -1.149 | 2.248 | -269 | -417 | -1.895 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 305 | 160 | 2.402 | 11.244 | 23.048 |
| Equity | -2.124 | 124 | 1.677 | 8.163 | 20.084 |
| Long-term debt | 2.290 | 0 | 0 | 0 | 0 |
| Short-term debt | 140 | 36 | 725 | 2.936 | 1.988 |
| Total debt | 2.430 | 36 | 725 | 2.936 | 1.988 |
EBITDA margin
-660.3%
This company
15.8%
Market median
-4279% vs market
20202024
Equity ratio
87.1%
This company
38.2%
Market median
+128% vs market
20202024
Return on equity
-9.4%
This company
18.4%
Market median
-151% vs market
20202024
Net profit margin
-482.9%
This company
8.1%
Market median
-6062% vs market
20202024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20202024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LH Founder | Founder | 2017 |
RH Management | Management | 2021 |
| Former (1) | ||
GJ Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2021 | |
| Former (6) | ||
| Board of Directors | 2019 – 2020 | |
| Chairman | 2017 – 2017 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2017 – 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25–33.32% | 25–33.32% | 2025 | |
| Individual | 10–14.99% | 10–14.99% | 2025 | |
| Company | 10–14.99% | 10–14.99% | 2024 | |
| Company | 10–14.99% | 10–14.99% | 2025 | |
| Company | 20–24.99% | 20% | 2017 | |
| Company | 20–24.99% | 20–24.99% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MARIE ULSTRUP INVEST ApS
UV Clinical A/S Board members of UV Clinical A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Helth Jensen | Founder | 0 companies |
| Gitte Jürgens | Chief Executive Officer | 0 companies |
| Rolf Henrik Sprunk-Jansen | Management | 0 companies |
| Brian Schebye | Board of Directors | 0 companies |
| Gustaf Iuel-Brockdorff | Chairman | 0 companies |
| Emilio de la Guardia Gascuñana | Board of Directors | 0 companies |
| Jan Friis Schack | Board of Directors | 0 companies |
| Claus Frisenberg Pedersen | Board of Directors | 0 companies |
| Carsten Viftrup Andersen | Board of Directors | 0 companies |
| Anne Sophie Winther Hansen | Chairman | 0 companies |
| Helge Holm-Larsen | Chairman | 0 companies |